ID

12252

Beskrivning

An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients NCT00090051 Roche BO17072 Treatments given for an adverse event should be recorded on the appropriate “Adverse event” page. Treatments given for prophylaxis or treatment of abnormal laboratory values (e.g. blood cells, potassium supplements, etc.) should be recorded on this page. List any treatments continuing at screen or that have begun since screen (or medical procedures performed) that are not recorded on Adverse event pages.

Nyckelord

Versioner (2)
  1. 2015-09-30 2015-09-30 -
  2. 2015-10-28 2015-10-28 -
Uppladdad den

28 oktober 2015

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0 Legacy
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

CLL Concomitant Treatments BO17072 NCT00090051

Engelsk

Concomitant Treatmants Chronic Lymphocytic Leukemia BO17072 NCT00090051

1 Formulär  
Concomitant treatments (or medical procedures) other than for CLL
Beskrivning

Concomitant treatments (or medical procedures) other than for CLL

Treatments given for an adverse event should be recorded on the appropriate “Adverse event” page. Treatments given for prophylaxis or treatment of abnormal laboratory values (e.g. blood cells, potassium supplements, etc.) should be recorded on this page. List any treatments continuing at screen or that have begun since screen (or medical procedures performed) that are not recorded on Adverse event pages.
Beskrivning

Info

Datatyp

text

Name of concomitant treatment
Beskrivning

Name of treatment

Datatyp

text

Alias
UMLS CUI [1]
C1707479
Total Daily Dose of Agent (or Drug)
Beskrivning

Concomitant Medication Daily Dose

Datatyp

float

Måttenheter
  • mg
Alias
UMLS CUI [1]
C2826638
mg
Start date
Beskrivning

Concomitant Medication Start Date

Datatyp

date

Måttenheter
  • dd/mm/yy
Alias
UMLS CUI [1]
C2826734
dd/mm/yy
End Date
Beskrivning

Concomitant Medication End Date

Datatyp

date

Måttenheter
  • dd/mm/yy
Alias
UMLS CUI [1]
C2826744
dd/mm/yy
Ongoing
Beskrivning

Concomitant Medication Ongoing

Datatyp

boolean

Alias
UMLS CUI [1]
C2826666
Concomitant Medication Use Reason
Beskrivning

Concomitant Medication Use Reason

Datatyp

text

Alias
UMLS CUI [1]
C2347852
Tillbaka till toppen

Similar models

Concomitant Treatmants Chronic Lymphocytic Leukemia BO17072 NCT00090051

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Concomitant treatments (or medical procedures) other than for CLL
Info
Item
Treatments given for an adverse event should be recorded on the appropriate “Adverse event” page. Treatments given for prophylaxis or treatment of abnormal laboratory values (e.g. blood cells, potassium supplements, etc.) should be recorded on this page. List any treatments continuing at screen or that have begun since screen (or medical procedures performed) that are not recorded on Adverse event pages.
text
Name of treatment
Item
Name of concomitant treatment
text
C1707479 (UMLS CUI [1])
Concomitant Medication Daily Dose
Item
Total Daily Dose of Agent (or Drug)
float
C2826638 (UMLS CUI [1])
Concomitant Medication Start Date
Item
Start date
date
C2826734 (UMLS CUI [1])
Concomitant Medication End Date
Item
End Date
date
C2826744 (UMLS CUI [1])
Concomitant Medication Ongoing
Item
Ongoing
boolean
C2826666 (UMLS CUI [1])
Concomitant Medication Use Reason
Item
Concomitant Medication Use Reason
text
C2347852 (UMLS CUI [1])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial